CN1151820C

CN1151820C - Traditional Chinese medicine for treating rheumatic heart disease

Info

Publication number: CN1151820C
Application number: CNB011280719A
Authority: CN
Inventors: 徐凤玉
Original assignee: Individual
Current assignee: Individual
Priority date: 2001-08-21
Filing date: 2001-08-21
Publication date: 2004-06-02
Anticipated expiration: 2021-08-21
Also published as: CN1336227A

Abstract

The present invention relates to a traditional Chinese medicine for treating rheumatic heart diseases, which comprises the following components: 25g of vermilion, 50g of amber, 30g of radix codonopsitis, 30g of dwarf lilyturf tuber, 30g of hemlock parsley, 30g of nutgrass galingale rhizome, 30g of villous amomum fruit, 30g of tuckahoe, 30g of houbu, 30g of rhizoma corydalis, 30g of dried tangerine peel, 30g of ventriculi galli mucosa, 30g of bupleurum root, 30g of concha hallotidis, 20g of licorice root, and 20g of rhizoma zingiberis; the components are respectively pulverized into powder to be evenly mixed; after the powder is sterilized, the powder is respectively encapsuled to form finished products. The present invention has the advantages of good curative effect, obvious effect, high healing rate, no side effect, simple technology, low manufacturing cost, etc.

Description

The Chinese medicine of treatment rheumatic heart disease

(1) technical field

The invention belongs to a kind of Chinese medicine for the treatment of rheumatic heart disease.

(2) technical background

Rheumatic heart disease (abbreviation rheumatic heart disease) is common a kind of heart disease, is the consequence that the rheumatism pathological changes is invaded heart, shows as the narrow or incompetence of valve orifice, and the woman is more than the man among the patient.Impaired valve, also can be got involved by several valves for the most common simultaneously with Bicuspid valve, is called combined valvular lesion.Because the valve inflammation is shown effect repeatedly, valve thickens and shortening, adhesion and fibrosis cause valvular insufficiency and narrow.In early days can be asymptomatic, passing in time produces cardiac enlargement, arrhythmia, generally heart failure progressively occurs through 10-15.Rheumatic heart disease belongs to categories such as the cardiopalmus, palpitation with a distress feeling of motherland's medical science, due to the polyphyly QI and blood stasis of blood, and heart governing blood and vessels, promoting the circulation of blood is unable, and blood vessels are the Lip river not, thus uncomfortable in chest, chest pain, stringy and thready pulse or knot generation.At present, a lot of at the medicine of treatment rheumatic heart disease, but exist defectives such as price height, curative effect is slow, cure rate is lower.

(3) summary of the invention

Purpose of the present invention provides that a kind of cost is low, good effect, instant effect, to the Chinese medicine of all medicable treatment rheumatic heart diseases such as the heart failure due to the rheumatic heart disease, weak, arrhythmia, myocarditis, the stabbing pain of chest and spleen.

The technical scheme that adopts is:

The Chinese medicine of treatment rheumatic heart disease is to be hybridly prepared into through pulverizing by Cinnabaris, succinum, platform Radix Codonopsis, Radix Ophiopogonis, Rhizoma Chuanxiong, Rhizoma Cyperi, Fructus Amomi, Poria, Cortex Magnoliae Officinalis, Rhizoma Corydalis, Pericarpium Citri Reticulatae, Endothelium Corneum Gigeriae Galli, Radix Bupleuri, Concha Haliotidis, Radix Glycyrrhizae, Rhizoma Zingiberis.Its compatibility be Cinnabaris 10-45g, succinum 20-70g, platform Radix Codonopsis 10-50g, Radix Ophiopogonis 10-50g, Rhizoma Chuanxiong 10-50g, Rhizoma Cyperi 10-50g, Fructus Amomi 10-50g, Poria 10-50g, Cortex Magnoliae Officinalis 10-50g, Rhizoma Corydalis 10-50g, Pericarpium Citri Reticulatae 10-50g, Endothelium Corneum Gigeriae Galli 10-50g, Radix Bupleuri 10-50g, Concha Haliotidis 10-50g, Radix Glycyrrhizae 10-30g, Rhizoma Zingiberis 10-30g.

The process of the Chinese medicine of treatment rheumatic heart disease is:

Get Cinnabaris 10-45g, succinum 20-70g, platform Radix Codonopsis 10-50g, Radix Ophiopogonis 10-50g, Rhizoma Chuanxiong 10-50g, Rhizoma Cyperi 10-50g, Fructus Amomi 10-50g, Poria 10-50g, Cortex Magnoliae Officinalis 10-50g, Rhizoma Corydalis 10-50g, Pericarpium Citri Reticulatae 10-50g, Endothelium Corneum Gigeriae Galli 10-50g, Radix Bupleuri 10-50g, Concha Haliotidis 10-50g, Radix Glycyrrhizae 10-30g, Rhizoma Zingiberis 10-30g and be ground into the powder face respectively, by the compatibility mix homogeneously of getting it filled, after sterilization, divide the capsule of packing into to be finished product.

The side separates:

Cinnabaris: the effect that energy tranquilizing mind, detoxifcation make eye bright, so the good medicine of treatment cardiopalmus:

Succinum: can tranquillizing the mind by relieving convulsion, relieving stranguria by diuresis, promoting blood circulation to remove blood stasis, so primary disease select medicine;

Platform Radix Codonopsis: the effect of energy invigorating the spleen and replenishing QI;

Rhizoma Chuanxiong: the effect of blood-activating and qi-promoting, wind-expelling pain-stopping is arranged, so the cardiopathic medicine that selects of treatment rheumatism;

Radix Glycyrrhizae: have heat-clearing and toxic substances removing, invigorating the spleen and replenishing QI, lung moistening to eliminate the phlegm, delay and exempt from the effect of pain relieving;

Rhizoma Cyperi: the effect that the regulate the flow of vital energy logical stasis of blood, menstruction regulating and pain relieving are arranged;

Rhizoma Corydalis: the merit of reducing fever by reconciliation is arranged, and dispersing the stagnated live-QI to relieve the stagnation of QI, ascending up spleen-Qi and Yang be basis, so the good medicine of primary disease;

Endothelium Corneum Gigeriae Galli: can prohibit the dysentery leakage and collapse, can only lose and the seminal emission effect;

Poria: the light infiltration profit of energy, spleen invigorating invigorating middle warmer, mind tranquilizing and the heart calming, the disease of effecting a permanent cure good medicine;

Radix Bupleuri: reducing fever by reconciliation, dispersing the stagnated live-QI to relieve the stagnation of QI, ascending up spleen-Qi and Yang, so primary disease selects medicine;

Radix Ophiopogonis: quench one's thirst and dispel tired, reinforcing the heart lung heat clearing, deficiency-heat, insufficiency of heart-YIN, dysphoria and insomnia are had special effect from peace, so the treatment primary disease select medicine;

Rhizoma Zingiberis: recuperating depleted YANG, warming middle-JIAO, warming the lung for resolving phlegm, warming the meridian for stopping bleeding;

Pericarpium Citri Reticulatae: can manage it loose bitter temperature, dampness, regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm effect are arranged;

Fructus Amomi: during the stomach function regulating of being amusing, circulation of qi promoting are transferred, the capable spleen removing dampness of tool, the antiabortive function of circulation of qi promoting;

Cortex Magnoliae Officinalis: can manage it and loose, hardship and drop-down, bitter wet dampness, relieving distension by promoting circulation of QI, the effect of full, the drying dampness to eliminate phlegm of diarrhea due to stagnation of QI are down arranged;

Concha Haliotidis: the function for the treatment of dizzy blurred vision, convulsion with spasms, consumptive fever hectic fever due to YIN-deficiency, the heat clearing away of cold energy, suppressing the hyperactive liver and subsiding YANG being arranged is arranged.

Separate as can be known from above-mentioned side, medication of the present invention is reasonable, the compatibility science, and curative effect is obvious.

Advantages such as the present invention has good effect, instant effect, cure rate height, has no side effect, technology is simple, low cost of manufacture, all effective in cure to diseases such as the heart failure due to the rheumatic heart disease, weak, not agent of the rhythm of the heart, myocarditis, the stabbings pain of chest and spleen, thereby, reached the purpose for the treatment of both the principal and secondary aspects of a disease.

Take observation through 120 routine rheumatisants, effective percentage 100%, cure rate 90%.

Instructions of taking: oral every day secondary, each 3g, warm water delivery service.

(4) specific embodiment

Embodiment:

The Chinese medicine of treatment rheumatic heart disease is to be hybridly prepared into through pulverizing by Cinnabaris, succinum, platform Radix Codonopsis, Radix Ophiopogonis, Rhizoma Chuanxiong, Rhizoma Cyperi, Fructus Amomi, Poria, Cortex Magnoliae Officinalis, Rhizoma Corydalis, Pericarpium Citri Reticulatae, Endothelium Corneum Gigeriae Galli, Radix Bupleuri, Concha Haliotidis, Radix Glycyrrhizae, Rhizoma Zingiberis.Its compatibility be Cinnabaris 25g, succinum 50g, platform Radix Codonopsis 30g, Radix Ophiopogonis 30g, Rhizoma Chuanxiong 30g, Rhizoma Cyperi 30g, Fructus Amomi 30g, Poria 30g, Cortex Magnoliae Officinalis 30g, Rhizoma Corydalis 30g, Pericarpium Citri Reticulatae 30g, Endothelium Corneum Gigeriae Galli 30g, Radix Bupleuri 30g, Concha Haliotidis 30g, Radix Glycyrrhizae 20g, Rhizoma Zingiberis 20g.

The method of manufacturing technology of the Chinese medicine of the treatment rheumatic heart disease of the foregoing description is:

Get Cinnabaris 25g, succinum 50g, platform Radix Codonopsis 30g, Radix Ophiopogonis 30g, Rhizoma Chuanxiong 30g, Rhizoma Cyperi 30g, Fructus Amomi 30g, Poria 30g, Cortex Magnoliae Officinalis 30g, Rhizoma Corydalis 30g, Pericarpium Citri Reticulatae 30g, Endothelium Corneum Gigeriae Galli 30g, Radix Bupleuri 30g, Concha Haliotidis 30g, Radix Glycyrrhizae 20g, Rhizoma Zingiberis 20g and be ground into the powder face respectively, mix homogeneously, after sterilization, divide the capsule of packing into to be finished product.

Claims

1, the Chinese medicine of treatment rheumatic heart disease is characterized in that it being to be pulverized by the flavour of a drug of following weight proportion to be mixed and made into: Cinnabaris 10-45g, succinum 20-70g, platform Radix Codonopsis 10-50g, Radix Ophiopogonis 10-50g, Rhizoma Chuanxiong 10-50g, Rhizoma Cyperi 10-50g, Fructus Amomi 10-50g, Poria 10-50g, Cortex Magnoliae Officinalis 10-50g, Rhizoma Corydalis 10-50g, Pericarpium Citri Reticulatae 10-50g, Endothelium Corneum Gigeriae Galli 10-50g, Radix Bupleuri 10-50g, Concha Haliotidis 10-50g, Radix Glycyrrhizae 10-30g, Rhizoma Zingiberis 10-30g.

2, medicine according to claim 1, the weight proportion of the medicine that it is characterized in that respectively distinguishing the flavor of is: Cinnabaris 25g, succinum 50g, platform Radix Codonopsis 30g, Radix Ophiopogonis 30g, Rhizoma Chuanxiong 30g, Rhizoma Cyperi 30g, Fructus Amomi 30g, Poria 30g, Cortex Magnoliae Officinalis 30g, Rhizoma Corydalis 30g, Pericarpium Citri Reticulatae 30g, Endothelium Corneum Gigeriae Galli 30g, Radix Bupleuri 30g, Concha Haliotidis 30g, Radix Glycyrrhizae 20g, Rhizoma Zingiberis 20g.